Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Pierre‐Yves Courand

ResearcherPublications, citations & collaboration network

Pierre‐Yves Courand is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 223 works, 4,663 citations, an h-index of 31 and an i10-index of 63.

223
Works
4,663
Citations
31
h-index
63
i10-index

How has Pierre‐Yves Courand's publication output changed over time?

ScholarIQpublication output · 2015–2026

Output grew0% over the shown period — from 1 works in 2015 to 1 in 2026.

1
1
1
1
1
1
2
1
1
1
2015201620172018201920202021202220232026

What are the most-cited papers on Pierre‐Yves Courand?

ScholarIQmost cited works
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial
Michel Azizi, Roland E. Schmieder, Felix Mahfoud, Michael A. Weber, Joost Daemen, Justin Davies, Jan Basile, Ajay J. Kirtane, Yale Wang, Melvin D. Lobo, Manish Saxena, Lida Feyz, Florian Rader, Philipp Lurz, Jeremy Sayer, Marc Sapoval, Terry Levy, Kintur Sanghvi, Josephine Abraham, Andrew S.P. Sharp, Naomi D.L. Fisher, Michael J. Bloch, Helen Reeve-Stoffer, Leslie Coleman, Christopher M. Mullin, Laura Mauri, Yale Wang, Desmond Jay, Nedaa Skeik, Robert Schwartz, Florian Rader, Suhail Dohad, Ronald G. Victor, Kintur Sanghvi, Josh Costello, Courtney Walsh, Josephine Abraham, Theophilus Owan, Anu Abraham, Naomi D.L. Fisher, Laura Mauri, Piotr Sobieszczky, Jonathan S. Williams, Michael J. Bloch, Chanwit Roongsritong, Thomas Todoran, Jan Basile, Eric R. Powers, Emily Hodskins, Pete Fong, Cheryl L. Laffer, James Gainer, Mark Robbins, John P. Reilly, Michael Cash, Jessie Goldman, Sandeep Aggarwal, Gary S. Ledley, David H. Hsi, Scott Martin, Edward Portnay, David Calhoun, Thomas McElderry, William Maddox, Suzanne Oparil, Pei-Hsiu Huang, Powell Jose, Matheen Khuddus, Suzanne Zentko, James O’Meara, Ilie Barb, Joseph Garasic, Doug Drachman, Randy Zusman, Kenneth Rosenfield, Chandan Devireddy, Janice P. Lea, Bryan J. Wells, Rick Stouffer, Alan Hinderliter, Eric Pauley, Srinivasa Potluri, Scott Biedermann, Sripal Bangalore, Stephen Williams, David Zidar, Mehdi Shishehbor, Barry Effron, Marco Costa, Ajay J. Kirtane, Jai Radhakrishnan, Melvin D. Lobo, Manish Saxena, Anthony Mathur, Ajay Jain, Jeremy Sayer, Sudha Ganesh Iyer, Nicholas Robinson, Sadat Ali Edroos, Terry Levy
The Lancet. 2018721 CitationsOPEN ACCESS
Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial
Michel Azizi, Marc Sapoval, Philippe Gosse, Matthieu Monge, Guillaume Bobrie, Pascal Delsart, Marco Midulla, Claire Mounier‐Véhier, Pierre‐Yves Courand, Pierre Lantelme, Thierry Denolle, Caroline Dourmap-Collas, Hervé Trillaud, Héléna Pereira, Pierre‐François Plouin, Gilles Châtellier
The Lancet. 2015518 Citations
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial
Michel Azizi, Kintur Sanghvi, Manish Saxena, Philippe Gosse, John P. Reilly, Terry Levy, Lars Christian Rump, Alexandre Persu, Jan Basile, Michael J. Bloch, Joost Daemen, Melvin D. Lobo, Felix Mahfoud, Roland E Schmieder, Andrew Sharp, Michael A. Weber, Marc Sapoval, Pete Fong, Atul Pathak, Pierre Lantelme, David H. Hsi, Sripal Bangalore, Adam Witkowski, Joachim Weil, Benjamin Kably, Neil C. Barman, Helen Reeve-Stoffer, Leslie Coleman, Candace K. McClure, Ajay J Kirtane, Kintur Sanghvi, Josh Costello, Courtney Krathan, Luot Lewis, Andrew McElvarr, John P. Reilly, Stephen J. Jenkins, Michael Cash, Shannon Williams, Maria Jarvis, Pete Fong, Cheryl L. Laffer, James Gainer, Mark Robbins, Sherron Crook, Sarita Maddel, David H. Hsi, Scott Martin, Edward Portnay, Maryanne Ducey, Suzanne Rose, Elizabeth DelMastro, Sripal Bangalore, Stephen Williams, Stanley Cabos, Carolina Rodríguez Álvarez, Thomas Todoran, Jan Basile, Eric R. Powers, Emily Hodskins, Vijay Paladugu, Anna Tecklenburg, Chandan Devireddy, Janice P. Lea, Bryan J. Wells, Amanda Fiebach, Claudia Merlin, Florian Rader, Suhail Dohad, H. Mike Kim, Mohammad A Rashid, Josephine Abraham, Theophilus Owan, Anu Abraham, Iran Lavasani, Hailey Neilson, David Calhoun, Thomas McElderry, William Maddox, Suzanne Oparil, Sheila Kinder, Ajay J Kirtane, Jai Radhakrishnan, Candido Batres, Suzanne Edwards, Joseph Garasic, Doug Drachman, Randy Zusman, Kenneth Rosenfield, Danny Do, Matheen Khuddus, Suzanne Zentko, James O’Meara, Ilie Barb, Abby Foster, Alice Boyette, Yale Wang, Desmond Jay, Nedaa Skeik, Robert Schwartz
The Lancet. 2021421 CitationsOPEN ACCESS
A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor–Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention
Spencer C. Wei, Wouter C. Meijers, Margaret L. Axelrod, Nana-Ama A.S. Anang, Elles M. Screever, Elizabeth C. Wescott, Douglas B. Johnson, Elizabeth M. Whitley, Lorenz Lehmann, Pierre‐Yves Courand, James J. Mancuso, Lauren E. Himmel, Bénédicte Lebrun-Vignes, Matthew J. Wleklinski, Björn C. Knollmann, Jayashree Srinivasan, Yu Li, Oluwatomisin T. Atolagbe, Xiayu Rao, Yang Zhao, Jing Wang, Lauren I. R. Ehrlich, Padmanee Sharma, Joe‐Elie Salem, Justin M. Balko, Javid J. Moslehi, James P. Allison
Cancer Discovery. 2020279 CitationsOPEN ACCESS
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
Markus P. Schlaich, M Bellet, Michael A. Weber, Parisa Danaietash, George L. Bakris, John M. Flack, Roland F. Dreier, Mouna Sassi-Sayadi, Lloyd Haskell, Krzysztof Narkiewicz, Ji‐Guang Wang, Christopher M. Reid, Markus P. Schlaich, Ivor Katz, Andrew E. Ajani, Sinjini Biswas, Murray Esler, Grahame J. Elder, Simon D. Roger, David Colquhoun, John G. Mooney, Tine De Backer, Alexandre Persu, Martin Chaumont, Jean-Marie Krzesinski, Thomas Vanassche, Ginette Girard, Lew Pliamm, Ernesto L. Schiffrin, Fatima Merali, George K. Dresser, Michel Vallée, Shivinder Jolly, S. P. Chow, Ji‐Guang Wang, Jianjun Mu, Jing Yu, Hong Yuan, Yingqing Feng, Xin Zhang, Jianhong Xie, Ling Lin, Miroslav Souček, J Widimský, Renata Cífková, J. Václavík, Martin Ullrych, Martin Lukáč, Ivan Rychlík, Thomas Guldager Lauridsen, Ilkka Kantola, Jyrki Taurio, Olavi Ukkola, Olivier Ormezzano, Philippe Gosse, Michel Azizi, Pierre‐Yves Courand, Pascal Delsart, Jean Michel Tartiere, Felix Mahfoud, Roland E. Schmieder, Johannes Stegbauer, Philipp Lurz, Michael Koziolek, Christian Ott, Nicole Toursarkissian, Konstantinos Tsioufis, K. Kyfnidis, Athanasios Manolis, Sotirios Patsilinakos, Pantelis Zebekakis, Apostolos Karavidas, Pall Denes, Katalin Bezzegh, Marianna Zsom, László Kovács, Yehonatan Sharabi, Mazen Elias, Ivetta Sukholutsky, Chaim Yosefy, Irina Kenis, Shaul Atar, Massimo Volpe, Muiesan Maria Lorenza, Stefano Taddei, Guıdo Grassı, Franco Veglio, Jung‐Woo Son, Jang‐Young Kim, Joong-Il Park, Chang Hoon Lee, Hae‐Young Lee, Rasa Raugalienė, Jolanta Elena Marcinkeviciene, Roma Kavaliauskiene, Jaap Deinum, Abraham A. Kroon, Bert‐Jan H. van den Born, Andrzej Januszewicz, Andrzej Tykarski
The Lancet. 2022235 CitationsOPEN ACCESS

Related on ScholarIQ

Lyon 1 Université
Institution
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial
Paper
Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial
Paper
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial
Paper
A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor–Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention
Paper
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
Paper
470M+ articles · free account